Search for: "Hyman, Phelps & McNamara, P.C."
Results 81 - 100
of 152
Sort by Relevance
|
Sort by Date
22 Dec 2011, 5:48 pm
Hyman, Phelps & McNamara, P.C. has prepared a summary of the proposed rule, which is available here. [read post]
21 Dec 2011, 11:02 pm
In a new Legal Backgrounder published by the Washington Legal Foundation, Hyman, Phelps & McNamara, P.C. [read post]
7 Dec 2011, 7:23 am
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks a mid-level to senior associate or counsel with substantial experience in medical device law and regulation to assist with a growing practice. [read post]
28 Nov 2011, 7:26 pm
” Hyman, Phelps & McNamara, P.C. [read post]
22 Nov 2011, 7:51 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
8 Nov 2011, 6:08 am
For the second year in a row, Hyman, Phelps & McNamara, P.C. has been ranked as a “Tier 1” law firm in the area of FDA Law (both nationally and in Washington DC) by the folks over at U.S. [read post]
7 Nov 2011, 10:17 am
Hyman, Phelps & McNamara, P.C. [read post]
19 Oct 2011, 3:30 pm
As we reported last week, the National Organization for Rare Disorders (“NORD”) released a landmark report (authored by Chairman of the NORD Board of Directors and Hyman, Phelps & McNamara, P.C. [read post]
11 Oct 2011, 1:53 pm
Chairman of the NORD Board of Directors and Hyman, Phelps & McNamara, P.C. [read post]
20 Sep 2011, 11:10 am
Hyman, Phelps & McNamara, P.C. [read post]
18 Sep 2011, 9:45 am
Wolszon – On August 31, Hyman, Phelps & McNamara, P.C. [read post]
8 Sep 2011, 12:26 pm
In late July, Hyman, Phelps & McNamara, P.C. filed a request for a one-year comment period to allow affected businesses adequate time to respond to the lengthy and controversial draft guidance (see our previous post here). [read post]
8 Sep 2011, 7:12 am
” In addition to the Report to Congress, NORD states in the petition that the organization’s requests are consistent with the recommendations of a recent finding of the Institute of Medicine, which released a report in October 2010, titled “Rare Diseases and Orphan Products: Accelerating Research and Development,” and with the testimony delivered by Hyman, Phelps & McNamara, P.C. [read post]
3 Aug 2011, 2:40 pm
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
3 Aug 2011, 10:41 am
Hyman, Phelps & McNamara, P.C. [read post]
2 Aug 2011, 11:32 am
Hyman, Phelps & McNamara, P.C. [read post]
26 Jul 2011, 5:29 pm
On July 26, 2011, Hyman, Phelps & McNamara, P.C. filed a request for a one-year comment period to allow affected businesses adequate time to respond to a lengthy and controversial draft guidance on New Dietary Ingredient ("NDI") notifications that FDA issued earlier this month. [read post]
18 Jul 2011, 5:16 pm
Watson, represented by Hyman, Phelps & McNamara, P.C. and Crowell & Moring, intervened in the case as an Intervenor-Defendant. [read post]
8 Jul 2011, 10:44 am
Fleder of Hyman, Phelps & McNamara, P.C. on... [read post]
7 Jul 2011, 3:38 pm
Lerner, David, Littenberg, Krumholz & Mentlik, LLP and Hyman, Phelps & McNamara, P.C. represent Nostrum in the lawsuit. [read post]
